Silverline Medi-Tech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 26 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 3.74 Cr
as on 16-11-2024
- Revenue -63.12%
(FY 2023)
- Profit -80.00%
(FY 2023)
- Ebitda -74.07%
(FY 2023)
- Net Worth 9.51%
(FY 2023)
- Total Assets 19.16%
(FY 2023)
About Silverline Medi-Tech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.00 Cr. The company has closed loans amounting to ₹3.74 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mithil Patel and Hasmukhbhai Patel serve as directors at the Company.
- CIN/LLPIN
U33112GJ1998PTC034800
- Company No.
034800
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Silverline Medi-Tech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mithil Patel  | Director | 19-Dec-2013 | Current |
| Hasmukhbhai Patel | Director | 09-Oct-1998 | Current |
Financial Performance of Silverline Medi-Tech.
Silverline Medi-Tech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 63.12% decrease. The company also saw a substantial fall in profitability, with a 80% decrease in profit. The company's net worth moved up by a moderate rise of 9.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Silverline Medi-Tech?
In 2023, Silverline Medi-Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Infitron Medical Technology Private LimitedActive 2 years 3 monthsMithil Patel and Hasmukhbhai Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Sep 2022 | ₹7.00 Cr | Open |
Hdfc Bank Limited Creation Date: 08 Jan 2021 | ₹2.00 Cr | Satisfied |
Deutsche Bank Ag Creation Date: 17 Jul 2014 | ₹1.10 Cr | Satisfied |
How Many Employees Work at Silverline Medi-Tech?
Silverline Medi-Tech has a workforce of 26 employees as of Jul 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Silverline Medi-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Silverline Medi-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
